FreeObituary Albert de la Chapelle, cancer genetics giant and a true gentleman, dies at 87 January 22, 2021Vol.47 No.03By Heather Hampel, Amanda E. Toland and Ann-Kathrin Eisfeld
Free Cancer groups expect bold moves reminiscent of the 2016 Moonshot as Biden tackles COVID-19, inequity, injustice January 22, 2021Vol.47 No.03By Matthew Bin Han Ong
Cancer History ProjectFree Gordon Zubrod’s panoramic vision shaped modern clinical cancer researchThe Cancer History Project finds and publishes Zubrod's autobiography January 15, 2021Vol.47 No.02By Otis W. Brawley and Paul Goldberg
Drugs & TargetsFree Tagrisso receives FDA approval as adjuvant therapy for NSCLC with EGFR mutations January 08, 2021Vol.47 No.01
Drugs & TargetsFree Iclusig receives FDA sNDA approval for adult patients with resistant or intolerant chronic-phase CML January 08, 2021Vol.47 No.01
Drugs & TargetsFree Xpovio receives FDA approval for refractory or relapsed multiple myeloma January 08, 2021Vol.47 No.01
Drugs & TargetsFree Orgovyx receives FDA approval for advanced prostate cancer January 08, 2021Vol.47 No.01
Drugs & TargetsFree Margenza receives FDA approval for metastatic HER2-positive breast cancer January 08, 2021Vol.47 No.01
